Unmatched allogeneic in utero stem cell transplantation (IUSCT) produces poor engraftment unless the fetus has congenital immunodeficiency, probably because of maternal and fetal immune responses to injected cells. We studied the functional haematopoietic potential of transduced GFP+ sheep AF stem cells, before and after autologous IUSCT. CD34+ cells were selected from first trimester sheep AF, transduced overnight and injected intravenously into NOD-SCID-gamma (NSG) mice.
can be achieved postnatally [1] . Finally, the maturation of the immune system during the fetal life allows new antigens to be introduced early in gestation without rejection, and can induce immunologic tolerance to these new antigens [2] .
Despite all the above, results of allogeneic IUSCT [3] in humans have been successful only for the treatment of congenital severe combined immunodeficiency (SCID) [4] . Allogeneic mesenchymal stem cells (MSCs) injected into fetuses affected with osteogenesis imperfecta successfully engrafted in only 2 out of 5 cases [4] .
Attempts to treat other diseases such as sickle cell disease [5] or metabolic storage disorders for example, have been unsuccessful.
In the last few years work conducted by Flake and colleagues [6] has demonstrated that this may be at least partially explained by the migration of the in utero injected cells into the maternal circulation and mounting of a rejection response, which could diminish the engraftment. This is most likely due in mice to activated maternal T cells which can cross the placenta in mice and destroy engrafted allogeneic cells [7] . In order to avoid this response, stem cells matched to the fetus or even the mother could be used. Fetal mice injected with congenic haematopoietic stem cells (HSCs) for example, all maintained stable, long-term, multilineage chimerism compared with fewer than 20% of allogeneic recipients [8] .
F o r P e e r R e v i e w 5 Alternatively, in monogenic disease, stem cells derived from the fetus itself could be used after genetic modification for treatment of a fetus affected by a congenital disease. Fetal stem cells can be easily derived during pregnancy from the amniotic fluid (AF) [9] [10] [11] . In particular, ckit+ amniotic fluid stem cells (AFSC) are characterized by long-term self-renewal, clonal properties and differentiation capabilities which defined them at a pre-pluripotent status [9, 12, 13] . They share with embryonic stem cells the expression of some stem markers (e.g. OCT4 and SSEA4), but they are not tumorigenic unless reprogrammed as induced pluripotent stem cells (iPS) [14] .
Using a sheep model we have previously shown the potential of transduced AF mesenchymal stem cells (AFMSCs) for autologous IUSCT [15] . After first trimester amniocentesis, AFMSCs could be isolated, cultured, transduced and transplanted back into the donor fetus as an in utero autologous transplant.
Engraftment of GFP transduced cells was detected two weeks after transplantation in various tissues and organs.
In this study we hypothesised that cells with haematopoietic potential were also present in sheep AF and could be used for autologous IUSCT. We used a recently developed novel sheep-specific CD34 antibody that identifies haematopoietic stem cells in the adult sheep bone marrow [16] . After selecting CD34+ cells from the AF, we transplanted them into NOD-SCID-gamma (NSG) immunocompromised mice to study their engraftment, and into donor fetal sheep after gene marking them using a viral vector for autologous IUSCT. 
Sheep animal procedures
Time-mated Romney breed ewes were used. Eight fetuses from four ewes provided first trimester amniotic fluid (AF, 300-700 ml, 60 to 64 days of gestation) that was collected at post mortem examination under sterile conditions and frozen, for later use in transplantation experiments into NSG mice. Ten fetuses from five ewes were used for in utero autologous transplantation experiments. Here, general anesthesia was induced with Ketamine (4mg/kg, Merial, UK) intravenously, and after intubation, the ewes were maintained on Isoflurane-Vet 3% (Merial, UK) in oxygen. Fetal measurements were confirmed by ultrasound [17] . The first procedure, ultrasoundguided amniocentesis, was performed in the first trimester (60 -64 days of gestation, term = 145 days) using a 22 Gauge, 15cm echo-tip needle (Cook Medical, USA).
Amniotic fluid (AF, 10ml) was withdrawn from each amniotic sac. Two days later ewes were re-anaesthetized as above for the second procedure, an ultrasoundguided intraperitoneal injection of freshly isolated and transduced CD34+ amniotic fluid stem (AFS) cells (2x10 4 , 1-2ml) into the donor fetus using a 22-gauge 15cm echo-tip disposable needle (Cook Medical, USA). To ensure correct needle placement within the peritoneal cavity, the needle was inserted through the anterior abdominal wall of the fetal sheep superior and lateral to the fetal bladder to avoid the umbilical arteries. Microbubbles observed moving within the peritoneal cavity as the cells were instilled confirmed correct needle placement. [17] .
At birth, lambs were weighed and measured (girth at umbilicus, biparietal diameter, standing height to shoulder) and assessed for wellbeing (time to standing, heart rate, respiratory rate, temperature, and oxygen saturation). Lambs were fed naturally with ewe breast milk. Lamb peripheral blood was collected from the jugular vein (No. 18 needles with 20ml syringe) at birth and every 2 weeks thereafter for flow cytometry analysis. Data on lamb growth and wellbeing were collected regularly until scheduled post mortem examination at 6 months of age. This was performed under general anesthesia to allow sterile collection of lamb bone marrow (BM) from multiple sites (sternum, femur, humerus and iliac crest) using a trocar needle, and sampling from all internal organs. Ewes underwent a scheduled post mortem examination with extensive tissue sampling at 3 months after birth once weaning was completed.
Isolation and characterization of sheep CD34+ AFS cells and adult BM cells
Fresh sheep CD34+AFS cells were selected using a sheep-specific primary monoclonal IgG1 CD34 antibody [16] immediately after fluid collection using MACS system (Miltenyi Biotec, Germany). The primary CD34 antibody was incubated with sheep AF total cells for 15 minutes on ice (1:100 concentration). After washing out the primary antibody, the secondary antibody (rat anti-mouse IgG1 MicroBeads, Miltenyi Biotec, Germany) was incubated with the previous cell suspension for15 minutes on ice (1:100 concentration). Before sorting, the MS columns were rinsed with PBS with 0.5% BSA. The CD34+ fraction of cells conjugated with microbeads was collected after washing three times with PBS. Adult sheep BM collected from the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Culture and viral transduction of sheep CD34+AFS or BM cells
Frozen CD34+AFS or BM cells were used immediately after thawing. The cell suspension was centrifuged at 1500rpm for 5 minutes, the supernatant was discarded and the thawed cells were resuspended in culture medium for viral transduction. Fresh or thawed CD34+AFS or thawed CD34+BM cells were transduced for 48 hours with a lentivector encoding the HIV-1 central polypurine tract element, the Spleen Focus Forming Virus LTR promoter, and the marker gene eGFP, at MOI=50 as previously describe [15] . The culture medium contained basal IMEM, 10% FBS, and StemSpan CC100, which contains a combination of cytokines including Flt-3, Stem cell factor (SCF), IL3, and IL6 (Stemcell Technologies, UK).
Fresh or frozen CD34+ AFS or frozen CD34+BM cells (1x10 5 ) were seeded in 24-well low attachment plates with culture medium for 48 hours (37 0 C, 5% CO 2 ). The lentivector (10ul, MOI=50) was added while seeding the cells into each well. After 48
hours of viral transduction, the cell suspension was washed and re-suspended in PBS for in utero autologous injection or NSG mice injection. At four and eight weeks after transplantation, NSG recipients were sedated using vaporised Isoflurane-Vet 5% in oxygen (VetTech Solutions Ltd, UK), and the peripheral blood was sampled from an incision on the tail made using a scalpel (No.
11 blade). Blood (100ul) was collected by pipette into a heparin-rinsed microcentrifuge tube. Red blood cells (RBC) lysis solution (1ml, 5-PRIME Inc, USA) was added to each blood sample for 5 minutes at room temperature. The sample was centrifuged (1500 rpm for 5 minutes), the supernatant was removed, and the procedure was repeated with RBC lysis solution until the pellet was clean. The pellet was resuspended in 300µl PBS for flow cytometry analysis of GFP+ cells.
At 12 weeks of age, all recipient mice were sedated (vaporised Isoflurane-Vet 5% in oxygen, VetTech Solutions Ltd, UK), and blood (0.5 to 1ml) was collected via intracardiac puncture using a 22 gauge needle. The mice were sacrificed by manual dislocation of cervical cord and underwent extensive post mortem examination and tissue harvest (liver, thymus, heart, striated muscle from thigh, lung, kidney, spleen, adrenal gland and gonad). Femoral bones were collected for retrieval of bone marrow. Liver and spleen samples were ground using a syringe plunger in a sterile dish, rinsed with PBS, then filtered through a cell strainer (40µm nylon mesh, BD, UK). The BM was flushed from the femoral bones with PBS using a 22 gauge needle with syringe and then strained. RBC lysis buffer (2ml) was added to each sample for 10 minutes at room temperature and then centrifuged (1500 rpm for 5 minutes). The supernatant was removed, the pellet was suspended in 300µl PBS, and washed and centrifuged again. The supernatant was discarded and the pellet was resuspended in 300µl PBS at 4°C for flow cytometry.
Flow cytometry for eGFP detection and analysis
Single cell suspensions of fetal or lamb spleen, liver and BM were prepared Ten thousand events were collected per sample.
eGFP+ signal was detected using FITC gating in all the organs of NSG mice, sheep and lambs. The organs from YFP+ mice were used as a positive control. To study transduction efficiency, the same FITC channel was used to gate the eGFP+ population, untransduced AFS cells were used as negative control, and AFS cells of YFP transgenic mice were used for the positive control. PCR to detect eGFP DNA was performed as previously described (Shaw et al, 2011) . DNA from sheep AFS cells transduced with eGFP was used as a positive control.
PCR for detection of eGFP DNA

Colony forming unit (CFU) assay
MethoCult® GF H4434 kit and M3434 kit (Stem Cell Technologies, Canada)
were used to perform CFU assays for sheep CD34+AFS or BM cells and NSG mice BM cells. CD34 + cells that were isolated by MACS were added into methylcellulose cocktail containing cytokines and growth factors (1x10 4 cells per plate). The mixture was vortexed and plated into sterile 35mm plates that were then incubated for 14 days (37°C, 5% CO 2 in humidified atmosphere). Colonies were then scored using an inverted microscope and colony forming unit-granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GEMM), colony forming unit-granulocyte, monocyte (CFU-G/M/GM) and burst-forming unit/CFU-erythroid (BFU/CFU-eE) were recorded.
Confocal microscopy
Fresh sheep and mouse tissues, embedded in OCT, were snap frozen in methyl-butane and liquid nitrogen and were cut into 10-15µm sections using a cryostat (OTF, Bright, UK). Blocking solution was prepared with 1% BSA, 0.15% sample slides were observed using confocal microscopy (Leica TCS SP5 II, Germany), and the images were analyzed with the software ImageJ (NIH, US). The green positive signal indicated the eGFP+ cells, and the red signal indicated hepatocytes staining with AFP.
Results
Sheep CD34+ AF cells and CD34 BM cells both have haematopoietic potential
Amniotic fluid (mean volume 487ml, range 300-700ml) collected from first trimester time mated sheep (n=8, mean gestational age 62 days, range 60-64) at post mortem examination showed a mean total cell count of 6.25 x10 6 (range 6- ( Figure 2E ). Moreover, the cells were also homogenously negative for CD14
(monocyte marker) and CD31 (endothelial cell marker; Figure 2E ).
Sheep CD34+ AF cells are effectively transduced with lentiviral vectors
Following selection of sheep CD34+ cells using MACS, cells from all three sources were transferred into ultra-low attachment 24-well plates at a seeding Figure 2F ). There was no significant difference in transduction efficiency of cells between the three cell sources.
Transduced sheep eGFP+ CD34+ cells engraft haematopoietic organs in NSG mice
The experimental design is shown in Figure Figure 3C ). Besides blood and BM, eGFP DNA was detected by PCR in the liver (8 out of 9 transplanted NSG mice), spleen (5 out of 9), and the adrenal gland (2 out of 9; Figure 4A ). There was no signal detectable in tissue samples from the heart, muscle, lung, kidney, thymus and gonad. PCR results were confirmed by FACS, and showed eGFP+ cells in the spleen and liver at 3 months after injection ( Figure 4B and C). Transplantation of transduced sheep
CD34+eGFP+ adult BM cells resulted in a slighter higher engraftment rate than cells from fresh AF and frozen AF sources, in the spleen (6.7%, 5.8%, and 5.2%), and in liver (15.6%, 14.3%, and 8.5%, Figure 4B ), but this difference did not reach significance. Only in the liver, did NSG mice that received frozen AF cells show a significantly lower engraftment than the other two groups (p<0.05, ANOVA; Figure   4C ). Immunofluorescence study showed the presence of eGFP+ cells in liver samples of all transplanted NSG mice, that were cuboid in shape, consistent with hepatocyte morphology ( Figure 4D ). Co-staining with alpha fetoprotein (AFP, Figure   4E ) showed a few double-stained cells providing further evidence of hepatocyte differentiation. The percentage of eGFP+ cells per high power field in liver samples was not significantly different among the three cell sources (1.2% to 1.8%) ( Figure   4F ).
Secondary transplantation into NSG mice
Secondary NSG mice were transplanted with BM cells collected from femoral bones of primary NSG mice recipients transplanted with frozen (n=3) and fresh (n=3) AF, and adult BM (n=2) CD34+ cells at 3 months time ( Figure 2 ). Freshly isolated BM cells (3x10 6 per recipient) were injected into the tail vein of secondary NSG recipients. As for primary transplantation, these mice were treated with a sub-lethal dose of irradiation one hour before transplantation. Survival to scheduled postmortem examination at three months was 100%. At one month after transplantation, eGFP+ cells could be detected in the peripheral blood of 6 out of 8 secondary transplanted animals (2 out of 3 frozen AF, 2 out of 3 fresh AF, and 2 out of 2 adult BM group, Figure 5A ). There was a significantly higher level of engraftment in the peripheral blood of secondary NSG recipients that were transplanted with the BM from transduced sheep CD34+eGFP+ BM cell injected NSG primary recipients compared with frozen AF and fresh AF groups. The percentage of eGFP+ cells in the peripheral blood of secondary transplanted mice was around 2 to 4%, and these levels were maintained up to the scheduled post-mortem examination at 3 months post-transplantation ( Figure 5B ). Flow cytometric analysis of other haematopoietic organs three months after transplantation showed the presence of eGFP+ cells in the liver, spleen, and BM of the secondary NSG recipients that also had eGFP+ cells in the peripheral blood. Animals exhibiting no eGFP+ cells in their peripheral blood also showed no engraftment in liver, spleen and BM. There were no eGFP+ cells detected in the thymus of any animals at three months after transplantation ( Figure   5B ). 
In utero autologous transplantation with sheep CD34+ AFS cells
Time-mated pregnant ewes (n=5, 10 twin fetuses) were studied ( Figure 1 ).
The overall survival to live-birth after the operative procedure was 50% (5 out of 10).
In one twin pregnancy, both fetuses miscarried within a week of the amniocentesis procedure. In another twin pregnancy, both fetuses had reduced fetal growth velocity around 100 days and were found to have died in utero at 126 days of gestation.
Bacterial cultures of endometrium showed evidence of endometritis with a coliform.
In a second twin pregnancy, one twin demised at 90 days of gestation, but the other continued to term and was born healthy. Fetal growth velocity was normal in all cases that survived to birth. Five lambs of three ewes were delivered at term. All lambs had normal initial assessments at birth (time to stand, heart rate, respiratory rate, O2 saturation and temperature) and birthweights were within the normal range.
In each of the born twin pairs, one twin lamb was rejected by the ewe and both lambs became dehydrated within 24 hours of birth. One ewe had obvious mastitis, but the other ewe did not. Despite artificial feeding, the lambs' condition deteriorated and an elective post-mortem examination was performed two days after birth on the advice of the veterinary surgeons. There was no evidence of structural abnormality or infection at post-mortem examination of these lambs. The remaining three lambs grew at a normal rate, and survived to scheduled post-mortem examination at 6 months of age.
Long-term engraftment in lambs after in utero autologous transplantation
eGFP+ cells were detected in the peripheral blood of all lambs that survived to birth (mean = 2.72%, range 1.6% to 4.5%, Figure 6B ). In those lambs that survived long-term, the peripheral blood remained eGFP+ up to scheduled post-mortem Figure 7A ), and also in the peripheral blood and liver (data not shown).
Secondary xenogeneic transplantation of AF-derived sheep haematopoieticrepopulating cells into NSG recipient mice
In order to further confirm the haematopoietic potential of CD34+ AF cells, whole unfractionated BM isolated from the transplanted lambs was transplanted into NSG secondary recipient mice (3X10 5 cells, n=9, with BM from one lamb being transplanted into three NSG recipients) with 100% survival to scheduled postmortem examination at three months post-transplantation. eGFP+ cells could be detected in the peripheral blood at 1, 2, and 3 months after secondary transplantation (2 out of 9 mice). At three months after secondary transplantation, eGFP+ cells were detected by flow cytometry in the liver, blood, and BM of secondary NSG recipient mice ( Figure 7B, 7C ). PCR analysis of haematopoietic tissues also demonstrated eGFP+ DNA in the liver, blood, BM, spleen and thymus ( Figure 7C ).
Discussion
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